Back to Journals » Vascular Health and Risk Management » Volume 3 » Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial
Please verify you are not a robot.